Other
UMC119-06-05
UMC119-06-05 is an intervention with 3 clinical trials. Currently 1 active trials ongoing.
Total Trials
3
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Active Trials
1(33%)
Phase Distribution
Ph phase_1
2
67%
Ph phase_2
1
33%
Phase Distribution
2
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 1Safety & dosage
2(66.7%)
Phase 2Efficacy & side effects
1(33.3%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Other(2)
Detailed Status
unknown2
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
N/A
Most Advanced
Phase 2
Trials by Phase
Phase 12 (66.7%)
Phase 21 (33.3%)
Trials by Status
unknown267%
recruiting133%
Recent Activity
1 active trials
Showing 3 of 3
recruitingphase_2
Treatment of Chronic Obstructive Pulmonary Disease by Infusion of Allogenic Mesenchymal Stem Cells
NCT06491043
unknownphase_1
Mesenchymal Stem Cells for The Treatment of Knee Osteoarthritis (KOA).
NCT04893174
unknownphase_1
Mesenchymal Stem Cells for The Treatment of Frailty Syndrome
NCT04914403
Clinical Trials (3)
Showing 3 of 3 trials
NCT06491043Phase 2
Treatment of Chronic Obstructive Pulmonary Disease by Infusion of Allogenic Mesenchymal Stem Cells
NCT04893174Phase 1
Mesenchymal Stem Cells for The Treatment of Knee Osteoarthritis (KOA).
NCT04914403Phase 1
Mesenchymal Stem Cells for The Treatment of Frailty Syndrome
All 3 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 3